Lyan Sclerosis is a often overlooked genital skin condition that significantly impacts those it affects. Current estimates suggest it affects about 1% of the population, although recent insights indicate the number may be higher. The condition is severely under-reported and underdiagnosed.

Patients with Lyan Sclerosis experience persistent itching, burning pain, and the tearing of vaginal and vulval tissues. These symptoms can severely interfere not just with intimate relationships, but with everyday activities like using the toilet and choosing appropriate clothing.

Due to its symptoms, Lyan Sclerosis is often misdiagnosed as thrush. However, unlike thrush, it is not caused by a fungal infection. Instead, it is believed to be an

Within the NHS, the predominant treatment approach for Lyan Sclerosis involves the application of steroids. These are effective for mitigating flare-ups and preventing exacerbation of the condition.

Since 2015, an innovative treatment using Platelet-Rich Plasma (PRP) has shown remarkable results in managing Lyan Sclerosis. PRP appears to rejuvenate affected tissue, significantly reducing symptoms and the frequency of flare-ups. This promising treatment offers hope for those seeking alternatives to traditional steroid therapies.

"I’ve been using PRP for Lyan Sclerosis since 2015 and I've seen incredible results..."

The ongoing success of PRP treatments signifies a major development in the management of Lyan Sclerosis, illustrating how modern medical advancements continue to improve patient outcomes.